170 related articles for article (PubMed ID: 37995046)
41. Assessment of interstitial lung disease among black rheumatoid arthritis patients.
McFarlane IM; Zhaz SY; Bhamra MS; Burza A; Kolla S; Alvarez MR; Koci K; Taklalsingh N; Pathiparampil J; Freeman L; Kaplan I; Kabani N; Ozeri DJ; Watler E; Frefer M; Vaitkus V; Matthew K; Arroyo-Mercado F; Lyo H; Zrodlowski T; Feoktistov A; Sanchez R; Sorrento C; Soliman F; Valdez FR; Dronamraju V; Trevisonno M; Grant C; Clerger G; Amin K; Dawkins M; Green J; Moon J; Fahmy S; Waite SA
Clin Rheumatol; 2019 Dec; 38(12):3413-3424. PubMed ID: 31471819
[TBL] [Abstract][Full Text] [Related]
42. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
Wolfe F; Michaud K
J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
[TBL] [Abstract][Full Text] [Related]
43. Increased Frailty in Individuals With Osteoarthritis and Rheumatoid Arthritis and the Influence of Comorbidity: An Analysis of the UK Biobank Cohort.
Cook MJ; Verstappen SMM; Lunt M; O'Neill TW
Arthritis Care Res (Hoboken); 2022 Dec; 74(12):1989-1996. PubMed ID: 34235888
[TBL] [Abstract][Full Text] [Related]
44. Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort.
Beltai A; Combe B; Coffy A; Gaujoux-Viala C; Lukas C; Saraux A; Dougados M; Daurès JP; Hua C
Joint Bone Spine; 2022 May; 89(3):105326. PubMed ID: 34906696
[TBL] [Abstract][Full Text] [Related]
45. [Long-term use of glucocorticoids in patients with active rheumatoid arthritis: therapeutic "freeze frame"].
Gordeev AV; Matyanova EV; Galushko EA
Ter Arkh; 2023 Jul; 95(5):380-385. PubMed ID: 38158989
[TBL] [Abstract][Full Text] [Related]
46. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia.
Gist AC; Guymer EK; Eades LE; Leech M; Littlejohn GO
Int J Rheum Dis; 2018 Mar; 21(3):639-646. PubMed ID: 28296177
[TBL] [Abstract][Full Text] [Related]
47. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
Dessein PH; Stanwix AE; Joffe BI
Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
[TBL] [Abstract][Full Text] [Related]
48. Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015.
England BR; Roul P; Yang Y; Sayles H; Yu F; Michaud K; Xie F; Curtis JR; Mikuls TR
Ann Rheum Dis; 2021 Mar; 80(3):286-292. PubMed ID: 33032999
[TBL] [Abstract][Full Text] [Related]
49. Influence of disease duration and socioeconomic factors on the prevalence of infection and hospitalization in rheumatoid arthritis: KRAC study.
Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
Int J Rheum Dis; 2019 Jul; 22(7):1216-1225. PubMed ID: 30977300
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology of rheumatoid arthritis, clinical aspects and socio-economic determinants in Pakistani patients: A systematic review and meta-analysis.
Naqvi AA; Hassali MA; Aftab MT
J Pak Med Assoc; 2019 Mar; 69(3):389-398. PubMed ID: 30890833
[TBL] [Abstract][Full Text] [Related]
51. The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis.
Hill J; Harrison J; Christian D; Reed J; Clegg A; Duffield SJ; Goodson N; Marson T
Br J Community Nurs; 2022 May; 27(5):232-241. PubMed ID: 35522453
[TBL] [Abstract][Full Text] [Related]
52. Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
Lichtiger A; Fadaei G; Tagoe CE
Clin Rheumatol; 2024 Mar; 43(3):895-905. PubMed ID: 38340224
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis.
An J; Nyarko E; Hamad MA
Clin Rheumatol; 2019 Oct; 38(10):2717-2726. PubMed ID: 31134504
[TBL] [Abstract][Full Text] [Related]
54. The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors.
Biggioggero M; Mesina F; Favalli EG
Biomed Res Int; 2019; 2019():6107217. PubMed ID: 30733963
[TBL] [Abstract][Full Text] [Related]
55. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study.
Kuan V; Denaxas S; Patalay P; Nitsch D; Mathur R; Gonzalez-Izquierdo A; Sofat R; Partridge L; Roberts A; Wong ICK; Hingorani M; Chaturvedi N; Hemingway H; Hingorani AD;
Lancet Digit Health; 2023 Jan; 5(1):e16-e27. PubMed ID: 36460578
[TBL] [Abstract][Full Text] [Related]
56. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.
Caimmi C; Crowson CS; Smith WM; Matteson EL; Makol A
J Rheumatol; 2018 May; 45(5):595-603. PubMed ID: 29449499
[TBL] [Abstract][Full Text] [Related]
57. Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis Prevention.
Giles JT
Clin Ther; 2019 Jul; 41(7):1246-1255. PubMed ID: 31196641
[TBL] [Abstract][Full Text] [Related]
58. Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia.
Zautra AJ; Fasman R; Parish BP; Davis MC
Pain; 2007 Mar; 128(1-2):128-35. PubMed ID: 17055648
[TBL] [Abstract][Full Text] [Related]
59. Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry.
England BR; Yun H; Chen L; Vanderbleek J; Michaud K; Mikuls TR; Curtis JR
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):231-239. PubMed ID: 34338449
[TBL] [Abstract][Full Text] [Related]
60. Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis.
Vu M; Carvalho N; Clarke PM; Buchbinder R; Tran-Duy A
J Rheumatol; 2021 Aug; 48(8):1221-1229. PubMed ID: 33323533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
